Original Research

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J

ClinicoEconomics and Outcomes Research 2016, 8:485-493

Published Date: 19 September 2016